BioSpace News Archive

Business

Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results

Tenon Medical, Inc. today announced plans to release financial results for the fourth quarter and full year 2023 ended December 31, 2023 after market close on Tuesday, March 12, 2024.

February 27, 2024

·

1 min read

Genetown

New Research Study for Patients With Ulcerative Colitis Now Available in Ogden, Utah

Adults in the Ogden, Utah area with moderately to severely active ulcerative colitis (UC) may have the opportunity to join a research study assessing a new investigational medication.

February 27, 2024

·

2 min read

BioMidwest

Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women’s Health

Biom Pharmaceutical, a microbiome biotech company, announced the publication of the results of the clinical study on VagiBiom® microbiome-based probiotic suppositories, the company’s flagship feminine care product.

February 27, 2024

·

5 min read

Drug Development

Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer

IMUNON, Inc. (NASDAQ: IMNN) announces that Memorial Sloan Kettering Cancer Center has joined MD Anderson Cancer Center in enrolling patients in a Phase 1/2 clinical trial evaluating IMUNON’s IMNN-001 in combination with bevacizumab in patients with advanced ovarian cancer.

February 27, 2024

·

6 min read

Genetown

Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy

Wave Life Sciences today announced its upcoming presentations at the 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, taking place March 3-6 in Orlando, FL.

February 27, 2024

·

6 min read

Biotech Beach

Halozyme to Participate in Upcoming Investor Conferences - February 27, 2024

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Dr. Helen Torley, president and chief executive officer, is scheduled to present and host investor meetings at the following investor conferences.

February 27, 2024

·

2 min read

Deals

NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million

NRx Pharmaceuticals, Inc. today announced the pricing of its underwritten public offering of shares of its common stock (or pre-funded warrants in lieu thereof) at a public offering price of $0.30 per share.

February 27, 2024

·

7 min read

Biotech Beach

Avidity Biosciences to Participate in Upcoming March 2024 Investor Conferences

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that Avidity management will be participating at the following upcoming conferences.

February 27, 2024

·

1 min read

Biotech Bay

Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)

Scilex Holding Company announced acceptance of an abstract for poster and oral presentation at the 2024 Annual Meeting of the American Academy of Pain Medicine which will take place on March 7-10, 2024 in Scottsdale, Arizona.

February 27, 2024

·

8 min read

CorNeat EverPatch Hits the US Market: Farewell to Traditional Ocular Tissue Grafts

CorNeat Vision, a leader in innovative medical device solutions, proudly introduces the CorNeat EverPatch, a pioneering synthetic tissue-integrating matrix designed to revolutionize ophthalmic surgeries.

February 27, 2024

·

2 min read